In vitro activation of lymphocytes from nonsmall cell cancer patients by interleukin 2 and anti-CD3 antibody

This publication has 27 references indexed in Scilit:

• Characterization of cells from invaded lymph nodes in patients with solid tumors. Lymphokine requirement for tumor-specific lymphoproliferative response.
  The Journal of Experimental Medicine, 1987
• A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
  New England Journal of Medicine, 1987
• Targeting of cytotoxic cells with cross-linked antibody heteroaggregates
  Molecular Immunology, 1986
• Lysis of autologous tumor cells by high‐density lymphocytes is potentiated by the streptococcal preparation OK432 (picibanil)
  International Journal of Cancer, 1986
• T cell nature of some lymphokine‐activated killer (LAK) cells. Frequency analysis of LAK precursors within human T cell populations and clonal analysis of LAK effector cells
  European Journal of Immunology, 1986
• Effect of anti-human pan-T monoclonal antibodies on lymphocyte proliferative and cytotoxic functions
  Cellular Immunology, 1985
• Regulation of immune response by antibodies: the importance of antibody and monocyte Fc receptor interaction in T-cell activation
  Immunology Today, 1985
• Lymphokine-activated killer (LAK) cells. Analysis of factors relevant to the immunotherapy of human cancer
  Cancer, 1985
• A rapid technique for isolation of viable tumor cells from solid tumors: Use of the tumor cells for induction and measurement of cell-mediated cytotoxic responses
  European Journal of Cancer and Clinical Oncology, 1982
• Lysis of tumor biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor.
  The Journal of Experimental Medicine, 1982